跳至主要内容
临床试验/KCT0000319
KCT0000319已完成未知

A randomized, Open-Label, Single dose, Crossover Study to Evaluate the Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers

Hanmi Pharm0 个研究点目标入组 54 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 45(Year)(—)
性别
Male

入选标准

  • 1)Age between 20 and 45
  • 2)Weight: over 55kg and 18.53)Have to give their consent to participating clinical trial by oneself

排除标准

  • Has a medical history of hypersensitivity to drug including PDE5 inhibitor and QTc>430ms or uncontrolled arrhythmia

研究者

发起方
Hanmi Pharm

相似试验